Brendan Frey is a Canadian computer scientist, entrepreneur, and engineer. He is the Founder and Chief Innovation Officer of Deep Genomics, a company he launched in 2015 to address the need for a new data- and AI-driven approach to genetic medicine. In his role, he ensures that the machine learning platform rapidly identifies drug candidates for IND-enabling work.